Vivos Therapeutics (VVOS) FCF Margin (2020 - 2026)
Vivos Therapeutics' (VVOS) quarterly FCF Margin came in at 69.98% in Q2 2026, up 4183.0% year-over-year from 1.63% in Q2 2025, and up 40.32% quarter-over-quarter from 117.25% in Q1 2026.
Powered by 
Analysis
Vivos Therapeutics (VVOS) FCF Margin (2020 - 2026) Analysis & Trends
Vivos Therapeutics (VVOS) has reported FCF Margin for 7 consecutive years, with 69.98% the latest figure, recorded in Q2 2026.
- On a quarterly basis, FCF Margin rose 4183.0% year-over-year to 69.98% in Q2 2026; TTM through Jun 2026 was 104.9%, a 382.0% increase from a year earlier, with the FY2025 full-year figure at 117.44%, down 2917.0% from the prior year.
- FCF Margin was 69.98% for Q2 2026 at Vivos Therapeutics, up from 117.25% in the prior quarter.
- Over five years, FCF Margin peaked at 60.7% in Q3 2025 and troughed at 213.78% in Q4 2025.
- A 5-year average of 107.74% and a median of 94.72% in 2023 frame the typical range for FCF Margin.
- Across the five-year window, FCF Margin surged 7274 bps in 2023 and tumbled 13090 bps in 2025, its largest moves.
- Over 5 years, FCF Margin stood at 81.01% in 2022, then declined by 11 bps to 89.62% in 2023, then increased by 8 bps to 82.88% in 2024, then slumped by 158 bps to 213.78% in 2025, then jumped by 67 bps to 69.98% in 2026.
- The last three FCF Margin figures came in at 69.98% (Q2 2026), 117.25% (Q1 2026), and 213.78% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Align Technology | 10.73 Bn | 9.63 Bn | 757.43 Mn | 14.87% |
| 2 | Envista Holdings | 4.22 Bn | 3.10 Bn | 407.00 Mn | 14.28% |
| 3 | Dentsply Sirona | 2.12 Bn | 1.88 Bn | 493.00 Mn | 6.12% |
| 4 | Milestone Scientific | 34.86 Mn | 32.25 Mn | 1.56 Mn | 4.55% |
| 5 | Dror Ortho-Design | 9.77 Mn | 9.68 Mn | - | - |
| 6 | Vivos Therapeutics | 3.20 Mn | 1.40 Mn | 2.95 Mn | -69.98% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -69.98% |
| Mar 31, 2026 | -117.25% |
| Dec 31, 2025 | -213.78% |
| Sep 30, 2025 | -60.70% |
| Jun 30, 2025 | -111.81% |
| Mar 31, 2025 | -130.04% |
| Dec 31, 2024 | -82.88% |
| Sep 30, 2024 | -113.78% |
| Jun 30, 2024 | -77.55% |
| Mar 31, 2024 | -78.01% |
| Dec 31, 2023 | -89.62% |
| Sep 30, 2023 | -89.49% |
| Jun 30, 2023 | -91.49% |
| Mar 31, 2023 | -97.95% |
| Dec 31, 2022 | -81.01% |
| Sep 30, 2022 | -140.25% |
| Jun 30, 2022 | -123.06% |
| Mar 31, 2022 | -170.69% |
| Dec 31, 2021 | -102.50% |
| Sep 30, 2021 | -97.98% |